Clinical presentation and treatment options for clear cell lung cancer: University of Cincinnati a case series and literature review of clear cell lung cancer

Ihab Eldessouki, Ola Gaber, Muhammad K. Riaz, Jiang Wang, Nagla Abdel Karim

Research output: Contribution to journalReview article

3 Scopus citations


Clear cell carcinomas are common finding in renal, ovarian and uterine carcinomas. However, clear cell lung cancer (CCLC), first described by Liebow and Castleman in 1963, is considered an extremely rare variant of lung tumors. The 2011 WHO classification of lung tumors considered CCLC as a rare cytologic feature of squamous cell or adenocarcinomas. It is no longer recognized as a formal subtype, albeit it can be referred to in the pathological diagnosis as "with clear cell features" even with marginal fractions of the tumor cells. Such recognition is needed since the variation in clinical features and outcome in this subset of patients. The disease has a clinically vague natural history, is characterized by slight female predominance and is often seen in the elderly. As frequently encountered with rare diseases, its clinical course and treatment options have many questions still yet to be answered. In this paper, we review both the natural history and treatment options mentioned in literature, in the light of our experience by reporting a case series of four patients diagnosed with CCLC and highlight their aspects.

Original languageEnglish (US)
Pages (from-to)2373-2376
Number of pages4
JournalAsian Pacific Journal of Cancer Prevention
Issue number9
StatePublished - Sep 1 2018
Externally publishedYes



  • Case serious
  • Clear cell
  • Lung cancer
  • Treatment

ASJC Scopus subject areas

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this